Wiring miRNAs to pathways: A topological approach to integrate miRNA and mRNA expression profiles

Nucleic Acids Research

Volumn 42, Issue 11, 2014, Pages

  Calura, Enrica ^a   Martini, Paolo ^a   Sales, Gabriele ^a   Beltrame, Luca ^b   Chiorino, Giovanna ^c   D'Incalci, Maurizio ^b   Marchini, Sergio ^b   Romualdi, Chiara ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Laboratory of Cancer Genomics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN MDM2; PROTEIN P53; UVOMORULIN;

ARTICLE; CELL SIGNALING ASSAY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE LOCATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERACTIONS WITH RNA; MATHEMATICAL COMPUTING; MICROGRAPHITE; MRNA EXPRESSION ASSAY; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; VALIDATION STUDY;

FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; RNA, MESSENGER; SOFTWARE; TRANSCRIPTOME;

EID: 84903174339     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku354     Document Type: Article

References (45)

1. Sales, G., Coppe, A., Bisognin, A., Biasiolo, M., Bortoluzzi, S. and Romualdi, C. (2010) MAGIA, a web-based tool for miRNA and genes integrated analysis. Nucleic Acids Res., 38, W352-W359.
2. Bisognin, A., Sales, G., Coppe, A., Bortoluzzi, S. and Romualdi, C. (2012) MAGIA2: From miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update). Nucleic Acids Res., 40, W13-W21.
3. Pritchard, C.C., Cheng, H.H. and Tewari, M. (2012) MicroRNA profiling: Approaches and considerations. Nat. Rev. Genet., 13, 358-369.
4. Huang, G.T., Athanassiou, C. and Benos, P.V. (2011) mirConnX: Condition-specific mRNA-microRNA network integrator. Nucleic Acids Res., 39, W416-W423.
5. Kurman, R.J. and Shih, I.-M. (2010) The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am. J. Surg. Pathol., 34, 433-443.
6. Vaughan, S., Coward, J.I., Bast, , Robert, C.J., Berchuck, A., Berek, J.S., Brenton, J.D., Coukos, G., Crum, C.C., Drapkin, R. et al. (2011) Rethinking ovarian cancer: Recommendations for improving outcomes. Nat. Rev. Cancer, 11, 719-725.
7. Sales, G., Calura, E., Cavalieri, D. and Romualdi, C. (2012) graphite-a bioconductor package to convert pathway topology to gene network. BMC Bioinformatics, 13, 20.
8. Kanehisa, M. and Goto, S. (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 28, 27-30.
9. Joshi-Tope, G., Gillespie, M., Vastrik, I., D'Eustachio, P., Schmidt, E., de Bono, B., Jassal, B., Gopinath, G.R., Wu, G.R., Matthews, L., Lewis, S., Birney, E. and Stein, L. (2005) Reactome: A knowledgebase of biological pathways. Nucleic Acids Res., 33, D428-D432.
10. Schaefer, C.F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T. and Buetow, K.H. (2009) PID: The pathway interaction database. Nucleic Acids Res., 37, D674-D679.
11. Hsu, S.-D., Lin, F.-M., Wu, W.-Y., Liang, C., Huang, W.-C., Chan, W.-L., Tsai, W.-T., Chen, G.-Z., Lee, C.-J., Chiu, C.-M. et al. (2011) miRTarBase: A database curates experimentally validated microRNA-target interactions. Nucleic Acids Res., 39(Suppl.1), D163-D169.
12. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X. and Li, T. (2009) miRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Res., 37, D105-D110.
13. Griffiths-Jones, S., Grocock, R.J., Van Dongen, S., Bateman, A. and Enright, A.J. (2006) miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 34(Suppl.1), D140-D144.
14. Dweep, H., Sticht, C., Pandey, P. and Gretz, N. (2011) miRWalk-database: Prediction of possible miRNA binding sites by walking the genes of three genomes. J. Biomed. Inform., 44, 839-847.
15. Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., Li, M., Wang, G. and Liu, Y. (2009) miR2Disease: A manually curated database for microRNA deregulation in human disease. Nucleic Acids Res., 37(Suppl.1), D98-D104.
16. Inui, M., Martello, G. and Piccolo, S. (2010) MicroRNA control of signal transduction.Nat. Rev. Mol. Cell Biol., 11, 252-263.
17. Martini, P., Sales, G., Massa, M.S., Chiogna, M. and Romualdi, C. (2013) Along signal paths: An empirical gene set approach exploiting pathway topology. Nucleic Acids Res., 41, e19.
18. Donato, M., Xu, Z., Tomoiaga, A., Granneman, J.G., MacKenzie, R.G., Bao, R., Than, N.G., Westfall, P.H., Romero, R. and Draghici, S. (2013) Analysis and correction of crosstalk effects in pathway analysis. Genome Res., 23, 1885-1893.
19. Marchini, S., Cavalieri, D., Fruscio, R., Calura, E., Garavaglia, D., Nerini, I.F., Mangioni, C., Cattoretti, G., Clivio, L., Beltrame, L. et al. (2011) Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: A retrospective study of two independent tumour tissue collections. Lancet Oncol., 12, 273-285.
20. Calura, E., Fruscio, R., Paracchini, L., Bignotti, E., Ravaggi, A., Martini, P., Sales, G., Beltrame, L., Clivio, L., Ceppi, L., Di Marino, M. et al. (2013) miRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities. Clin. Cancer Res., 19, 4114-4123.
21. Bolstad, B., Irizarry, R., Astrand, M. and Speed, T. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19, 185-193.
22. Weberpals, J.I., Koti, M. and Squire, J.A. (2011) Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer. Cancer Genet., 204, 525-535.
23. Prat, J. (2012) New insights into ovarian cancer pathology. Ann. Oncol., 23 (Suppl.10), x111-x117.
24. Chou, J.-L., Chen, L.-Y., Lai, H.-C. and Chan, M. W.Y. (2010) TGF-beta: Friend or foe? The role of TGF-beta/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy. Expert Opin. Ther. Targets, 14, 1213-1223.
25. Marchini, S., Fruscio, R., Clivio, L., Beltrame, L., Porcu, L., Nerini, I.F., Cavalieri, D., Chiorino, G., Cattoretti, G., Mangioni, C., Milani, R. et al. (2013) Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Eur. J. Cancer, 49, 520-530.
26. Kelemen, L.E. and Kbel, M. (2011) Mucinous carcinomas of the ovary and colorectum: Different organ, same dilemma. Lancet Oncol., 12, 1071-1080.
27. Choi, S.W. and Mason, J.B. (2000) Folate and carcinogenesis: An integrated scheme. J. Nutr., 130, 129-132.
28. De Meyer, T., Bijsmans, I.T., Van de Vijver, K.K., Bekaert, S., Oosting, J., Van Criekinge, W., van Engeland, M. and Sieben, N.L. (2009) E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas. J. Pathol., 217, 14-20.
29. Reimer, D., Sadr, S., Wiedemair, A., Stadlmann, S., Concin, N., Hofstetter, G., M̈ uller-Holzner, E., Marth, C. and Zeimet, A.G. (2007) Clinical relevance of E2F family members in ovarian cancer-an evaluation in a training set of 77 patients. Clin. Cancer Res., 13, 144-151.
30. Pei, D., Zhang, Y. and Zheng, J. (2012) Regulation of p53: A collaboration between Mdm2 and Mdmx. Oncotarget, 3, 228.
31. Mateescu, B., Batista, L., Cardon, M., Gruosso, T., de Feraudy, Y., Mariani, O., Nicolas, A., Meyniel, J.-P., Cottu, P., Sastre-Garau, X. et al. (2011) miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat. Med., 17, 1627-1635.
32. Yoshida, S., Furukawa, N., Haruta, S., Tanase, Y., Kanayama, S., Noguchi, T., Sakata, M., Yamada, Y., Oi, H. and Kobayashi, H. (2009) Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: A review. Int. J. Gynecol. Cancer, 19, 992-997.
33. Senanayake, U., Das, S., Vesely, P., Alzoughbi, W., Fr ̈ohlich, L.F., Chowdhury, P., Leuschner, I., Hoefler, G. and Guertl, B. (2012) miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis, 33, 1014-1021.
34. Wei, W., Kong, B. and Qu, X. (2012) Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features. J. Obstet. Gynaecol. Res., 38, 57-64.
35. Han, E.S., Burger, R.A., Darcy, K.M., Sill, M.W., Randall, L.M., Chase, D., Parmakhtiar, B., Monk, B.J., Greer, B.E., Connelly, P. et al. (2010) Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer. Gynecol. Oncol., 119, 484-490.
36. Voorham, Q.J., Rondagh, E.J., Knol, D.L., van Engeland, M., Carvalho, B., Meijer, G.A. and Sanduleanu, S. (2013) Tracking the molecular features of nonpolypoid colorectal neoplasms: A systematic review and meta-analysis. Am. J. Gastroenterol., 108, 1042-1056.
37. Fearon, E.R. (2011) Molecular genetics of colorectal cancer. Annu. Rev. Pathol., 6, 479-507.
38. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V. and Mendell, J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
39. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
40. Andorfer, C.A., Necela, B.M., Thompson, E.A. and Perez, E.A. (2011) MicroRNA signatures: Clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol. Med., 17, 313-319.
41. Søkilde, R., Vincent, M., Møller, A.K., Hansen, A., Høiby, P.E., Blondal, T., Nielsen, B.S., Daugaard, G., Møller, S. and Litman, T. (2014) Efficient identification of miRNAs for classification of tumor origin. J. Mol. Diagn., 16, 106-115.
42. Nag, S., Qin, J., Srivenugopal, K.S., Wang, M. and Zhang, R. (2013) The MDM2-p53 pathway revisited. J. Biomed. Res., 27, 254-271.
43. Pichiorri, F., Suh, S.-S., Rocci, A., De Luca, L., Taccioli, C., Santhanam, R., Zhou, W., Benson, , Don, M.J., Hofmainster, C., Alder, H. et al. (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell, 18, 367-381.
44. Kim, T., Veronese, A., Pichiorri, F., Lee, T.J., Jeon, Y.-J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.-S., Alder, H., Liu, C., Dejean, A. and Croce, C.M. (2011) p53 regulates epithelial to mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med., 208, 875-883.
45. Zhang, Y., Xiong, Y. and Yarbrough, W.G. (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92, 725-734.